Abstract

The objective of this study was to evaluate the association of egg consumption with blood pressure (BP) and glycated hemoglobin (HbA1c). In addition, it was assessed whether this association changes according to body weight status. This cross-sectional study is based on multicenter data from Spanish adult participants in the EVIDENT II trial. Egg consumption was assessed with a Food Frequency Questionnaire, and data on BP and HbA1c were collected using standardized procedures. Linear regression and ANCOVA models adjusted for the main confounders were performed. The analyses were stratified by body weight status. A total of 668 participants were analyzed (mean age 52.4 +/- 11.8 years, 62.3% women). Compared with lower consumption, higher egg consumption was associated with lower systolic (ss = - 6.15 +/- 1.74; p-for-trend = 0.017), diastolic (ss = - 4.41 +/- 1.03; p-for-trend = 0.002), and mean arterial pressure (ss = - 4.99 +/- 1.17; p-for-trend = 0.003) and with lower HbA1c (ss = - 0.19 +/- 0.06; p-for-trend = 0.019) levels. These associations lost statistical significance in the adjusted analyses. The results did not vary by body weight status. In conclusion, consumption of up to 1 egg per day is not associated with BP or HbA1c, even in overweight or obese individuals. Our findings suggested that this frequency of egg consumption is safe as part of a healthy diet and lifestyle for cardiometabolic risk.